<DOC>
	<DOCNO>NCT00577395</DOCNO>
	<brief_summary>The purpose trial compare difference bone microarchitecture distal radius month 12 postmenopausal osteopenic woman treat risedronate 150mg take month compare placebo .</brief_summary>
	<brief_title>Bone Microarchitecture Osteopenic Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Female : 40 57 year age inclusive cessation menstruation ( surgical natural ) 12 36 month prior study enrollment osteopenia defines follow : osteopenia define follow : Lumbar spine ( L1L4 ) Bone Mineral Density ( BMD ) T score 1 less 2.5 AND total hip T score great 2.5 OR Lumbar spine ( L1L4 ) BMD T score great 2.5 AND total hip T score 1 less 2.5 ; body mass index ( BMI ) 18 30 kg/m2 . history uncontrolled hyperparathyroidism , hyperthyroidism , osteomalacia use medication within 3 month start study drug impact bone metabolism glucocorticoid , estrogen , calcitonin , calcitriol , bisphosphonates parathyroid hormone hypocalcemia hypercalcemia cause</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>